Swiss team develop ‘microswimmer’ robot to deliver drugs through the body
LONDON (Reuters) – – A tiny sliver of elastic material swims along inside a narrow tube, coiling up and changing shape in response to the thickness of fluid and the…
J&J raises U.S. prices on around two dozen drugs
NEW YORK (Reuters) – Johnson & Johnson raised U.S. prices on around two dozen prescription drugs on Thursday, including the psoriasis treatment Stelara, prostate cancer drug Zytiga and blood thinner…
U.S. FDA approves Alexion Pharma’s blood disorder drug
(Reuters) – The U.S. Food and Drug Administration has approved Alexion Pharmaceuticals Inc’s blood disorder drug Ultomiris, the pharma regulator’s website showed on Friday. The drug aims to treat paroxysmal…
BrainStorm gets FDA okay for stem cell trial in MS patients
TEL AVIV (Reuters) – BrainStorm Cell Therapeutics Inc has received approval from the U.S. Food and Drug Administration to begin a clinical trial of its experimental stem cell treatment in…
Evofem shares surge as contraceptive gel meets late-stage trial goal
(Reuters) – Shares of Evofem Biosciences Inc jumped as much as 38 percent on Monday after its birth control gel showed effectiveness in a late-stage study, bringing the first hormone-free…
Physician assistant faces U.S. trial over Insys opioid kickbacks
(Reuters) – A former physician assistant is set to face trial in New Hampshire on Wednesday over charges he accepted kickbacks from Insys Therapeutics Inc to prescribe a highly addictive…
Gilead Sciences snares Roche veteran O’Day as CEO
(Reuters) – Drugmaker Gilead Sciences Inc on Monday named Roche Holding AG’s Daniel O’Day as its new chief executive, tapping an industry veteran to fill a management vacuum. FILE PHOTO:…
Johnson & Johnson’s multiple myeloma drug reduces risk of death in late-stage study
FILE PHOTO: A Johnson & Johnson building is shown in Irvine, California, U.S., January 24, 2017. REUTERS/Mike Blake (Reuters) – Johnson & Johnson’s blockbuster blood cancer drug Darzalex significantly reduced…
Congo approves clinical trials for Ebola treatments
KINSHASA (Reuters) – Congolese authorities have authorized clinical trials for four experimental Ebola treatments, which will allow researchers to collect valuable data about their effectiveness, the health ministry said on…
BioMarin sets stage early for hemophilia cure off-Broadway
(This version of the November 21st story has been refiled to show in paragraph 23 that Sangamo Therapeutics has six people in clinical trials) Cast members from the musical “Hemophilia:…